Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Scientists identify genomic 'fingerprint' for alcohol-induced heart failure

Scientists identify genomic 'fingerprint' for alcohol-induced heart failure

May 05, 2008

A person with dilated cardiomyopathy has an enlarged and stretched heart cavity, usually too weak to pump normally; most people will go on to develop heart failure. While clinicians know that up to 36 percent of all cases of dilated cardiomyopathy may be due to excessive drinking, it has been difficult to differentiate between alcohol-induced heart failure and heart failure due to idiopathic dilated cardiomyopathy. A first-of-its-kind study has found a way to both diagnose alcohol-induced heart failure and possibly reverse it through therapeutic interventions.

Results are published in the May issue of Alcoholism: Clinical & Experimental Research.




"Excessive alcohol consumption affects not only heart function but also its structure," said Judith K. Gwathmey, professor of medicine at Boston University School of Medicine, and corresponding author for the study. "These effects can be acute if the exposure is brief, but can become chronic with long-term drinking. Furthermore, long-term effects are more serious since they affect not only the function of heart muscle but also its structure in a non-reversible manner."

Heart failure is an end point rather than an early sign of defect, she added. "Which is why detection of the pathology is so important during the earlier phases of reduced heart function," she said. "With the fingerprinting or profiling that we now have at hand, we can begin to think of diagnostic test(s) or biomarker(s) that would enable earlier and more definitive diagnoses, better monitor clinical outcomes of cessation of drinking, as well as medical interventions."

For this research, study authors employed a microarray, a technique used to sort out which genes change in response to a disease state. They analyzed an array - containing 1,143 heart-specific oligonucleotide probes - that is normally used to screen ribonucleic acid (RNA) samples from transplant recipients and organ donors with alcohol-related heart failure. The researchers then compared messenger RNA (mRNA) from the hearts of persons with alcohol-related heart failure with mRNA from the hearts of persons who did not engage in excessive drinking.

Results indicate a genomic "fingerprint" or profile of de-regulated genes that are associated with alcohol-induced heart failure in humans.

"The etiology of alcohol-induced cardiomyopathy is unique and different from other forms of cardiomyopathy, especially the idiopathic dilated cardiomyopathy," said Gwathmey. "Alcohol-induced cardiomyopathy is associated with changes in contraction and structural components that result in a reduction in the heart's pumping ability as well as the relaxation and filling of the heart. It is also associated with a significant increase in genes that cause cell death."

While cessation of drinking may mitigate some of the alcohol-related damage to the heart, Gwathmey said there is a point at which heart failure becomes irreversible due to "architectural" changes that alcohol has caused in the heart.

"The 'architectural damage' we refer to is related to the decrease in cells which are responsible for holding all the cells together in the heart and keeping the normal structure and shape of the heart," she said. "Heart function is dependent on the tight connections of heart cells in order for it to work synchronously and efficiently. Any slippage in the alignment of the cells can have severe consequences on the function of the heart and result in a large dilated weak heart with poor pumping function. This damage occurs in addition to a high rate of cardiac cell death."

In the early stages of chronic drinking, the heart can be forgiving, Gwathmey noted. "If the person stops drinking, heart failure is often reversible and/or can significantly improve," she said. "In fact, some patients do not even need medication if caught early enough. However, in later stages the architectural damage and cell death become so great that the heart failure becomes irreversible. Heart cells are not mitogenic, which means they cannot divide or replace themselves through cell division. Nevertheless, through recent efforts much progress has been made with stem-cell research. Many investigators have obtained positive results through the injection of stem cells into the heart, although these experiments are preliminary."

One of the best ways to address alcohol-induced heart failure, she added, is through aggressive early intervention. "Now that we have this diagnostic marker or fingerprint, clinicians will be better able to monitor the progress of a patient who is being treated either medically or simply self reporting a cessation of drinking."

Alcoholism: Clinical & Experimental Research



Related Cardiomyopathy Current Events and Cardiomyopathy News Articles Cardiomyopathy Current Events and Cardiomyopathy News RSS Cardiomyopathy Current Events and Cardiomyopathy News RSS
Young athletes need dual screening tests for heart defects, study suggests
To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.

Texas Children's discharges first pediatric patient with implanted mechanical heart device
Texas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions.

New methods found useful for diagnosing myocarditis
Myocarditis is an important, and often unrecognized cause of dilated cardiomyopathy (DCM). Several new diagnostic methods, such as cardiac magnetic resonance imaging (MRI), are useful for diagnosing myocarditis, according to a study published in the November 2009 issue of Mayo Clinic Proceedings.

UT Southwestern patient first in North Texas to receive newest-generation heart failure device
UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant.

New data: Hospital imaging centers poised to pull back, hitting patients hardest in rural areas
Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final health care reform legislation.

Mechanism related to the onset of various genetic diseases revealed
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.

MDC researchers prevent virus induced myocarditis
Life-threatening cardiac arrhythmia can be a consequence of myocarditis - an inflammation of the cardiac muscle that can be caused by the Coxsackievirus.

Extra 'STICH' in bypass adds no benefit to quality of life
A surgical procedure to resize an enlarged, weakened heart muscle during coronary bypass surgery for heart failure adds cost and risk but doesn't offer patients any additional benefit when compared with those who received bypass procedure alone, according to researchers from the Duke Clinical Research Institute (DCRI).

New potential therapeutic target discovered for genetic disorder -- Barth syndrome
Researchers at NYU Langone Medical Center may have discovered a new targeted intervention for Barth Syndrome (BTHS). BTHS, a sometimes fatal disease, is a serious genetic disorder occurring predominantly in males that leads to infection or heart failure in childhood.

Studies point to novel target for treating arrhythmias
Abnormal heart rhythms - arrhythmias - are killers. They strike without warning, causing sudden cardiac death, which accounts for about 10 percent of all deaths in the United States.
More Cardiomyopathy Current Events and Cardiomyopathy News Articles
Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians

Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author)

When there is a diagnosis of HCM in a family, this complete, easy-to-read guide is your essential resource for finding the answers to your many questions. In clear and straightforward language, it explains what hypertrophic cardiomyopathy is, what the symptoms are, and how it can be treated, as well as reviewing the genetic implications and offering candid lifestyle advice.


Drawing on the expertise of Dr. Barry Maron, an internationally recognized authority on HCM, the book addresses major questions and concerns of both patients and families. Fully revised to reflect the latest developments, Hypertrophic Cardiomyopathy: For patients, their families and interested physicians, Second Edition, is a valuable source of straightforward advice and dependable information for everyone...

The Official Patient's Sourcebook on Dilated Cardiomyopathy

The Official Patient's Sourcebook on Dilated Cardiomyopathy
by James N. Parker (Editor), Philip M. Parker (Editor)

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to dilated cardiomyopathy (also cardiomyopathy - dilated; congestive cardiomyopathy), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on dilated cardiomyopathy. Given patients'...

Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy



Cardiomyopathy

Cardiomyopathy
Lifeline Audio Books (Primary Contributor)



Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)

Up-to-date information on available and forthcoming medical and surgical treatments.

How attitude and emotion affect heart failure--and what you can do to stay positive.

Tips for adopting a heart-healthy diet and lifestyle.

Ways to forge a positive working relationship with your doctor or cardiologist.



Cardio Well Classic (100 Capsules) Concentrated Herbal Blend - Dietary Supplement

Cardio Well Classic (100 Capsules) Concentrated Herbal Blend - Dietary Supplement
by Get Well Natural

Get Well Natural LLC's Cardio Well Classic contains a perfectly balanced combination of herbal ingredients exclusively formulated to support healthy heart and cardiovascular function.* This is crucial since poor heart function can lead to congestive heart failure, arteriosclerosis, abnormal heart enlargement, cardiomyopathy and some cases of resistant hypertension.* For these individuals, Cardio Well Classic offers superior ingredients to support the body in promoting healthy heart size, energy and proper dilation of the coronary artery.* For maximum health support over time, Cardio Well "Classic" can be taken for months at a time as a daily supplement to support continual health and longevity. Start today and experience improved heart health and overall circulation support for the...

Cardiomyopathies: Causes, Effects and Treatment

Cardiomyopathies: Causes, Effects and Treatment
by Peter H. Bruno (Editor), Matthew T. Giordano (Editor)

Cardiomyopathy is a type of heart disease in which the heart becomes abnormally enlarged, thickened and/or stiffened. As a result, the heart muscle's ability to pump and/or receive blood is impaired. This book describes the most recent advances in cardiomyopathies- one of the leading causes of hospitalisation worldwide. Dilated cardiomyopathy (DCM), also known as congestive cardiomyopathy, is a condition in which the heart becomes weakened and enlarged, and as a result, cannot pump blood efficiently. The causes, effects, as well as the severity of DCM are described in this book, as well as the types of therapy that are effective, such as anti-inflammatory or immunosuppressive therapy. There has been a general decrease of cardiac involvement in HIV-positive subjects in recent years due...

Understanding Cardiac Arrhythmias:  Current and Emerging Treatments

Understanding Cardiac Arrhythmias: Current and Emerging Treatments

Episodes of dizziness and loss of consciousness are unsettling and potentially life-threatening. But as our population ages, these problems become more common. Often, they stem from heart rhythm irregularities: cardiac arrhythmias. So how do we treat them? This program looks at different kinds of cardiac arrhythmias, as well as the variety of new and emerging treatments used to control them. Paul Wang, MD, is a Professor of Medicine in the Department of Cardiology at the Stanford University School of Medicine. His specialty is cardiology, with subspecialties in arrhythmias, atrial fibrillation, and syncope. His research interests include atrial fibrillation, pacemakers and defibrillators, catheter ablation, and hypertrophic cardiomyopathy. Dr. Wang was educated at the...

The Official Patient's Sourcebook on Hypertrophic Cardiomyopathy

The Official Patient's Sourcebook on Hypertrophic Cardiomyopathy
by James N. Parker (Editor), Philip M. Parker (Editor)

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to hypertrophic cardiomyopathy (also cardiomyopathy - hypertrophic; hypertensive hypertrophic cardiomyopathy; hypertrophic obstructive cardiomyopathy; idiopathic hypertrophic subaortic stenosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to...

  Improvement in hypertrophic cardiomyopathy after significant weight loss: case report. (Case Report).: An article from: Southern Medical Journal
by Gabriel I. Uwaifo (Author), Erica M. Fallon (Author), Karim A. Calis (Author), Bart Drinkard (Author), Jennifer R. McDuffie (Author), Jack A. Yanovski (Author)

This digital document is an article from Southern Medical Journal, published by Southern Medical Association on June 1, 2003. The length of the article is 3647 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Improvement in hypertrophic cardiomyopathy after significant weight loss: case report. (Case Report).
Author: Gabriel I. Uwaifo
Publication: Southern Medical Journal (Refereed)
Date: June 1, 2003
Publisher: Southern Medical Association
Volume: 96 Issue: 6 Page: 626(6)

Distributed by Thomson...

© 2009 BrightSurf.com